Purchase Order 75N95023P00458
- Not listed
- This is a $64,800 firm-fixed price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Psomagen Inc. for RNA sequencing services to support neurodegenerative disease research. The contract has a period of performance from August 1, 2024 to December 31, 2024. Psomagen will provide total RNA sequencing, including library preparation, sequencing, and data delivery, for 324 human samples. This is a non-competitive award, as Psomagen...
- This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract, valued at $4,942.00, is for DNA sequencing services. It is not a set-aside contract. The contract supports NIAID's research efforts, potentially including work on neurodegenerative diseases, cancer, and infectious diseases. Psomagen has previously received...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- The National Institute on Aging (NIA), a civilian agency within the U.S. government, has awarded a $237,440.00 firm fixed-price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide next-generation sequencing analysis services on post-mortem frontal cortex tissues. The contract has an ultimate completion date of July 31, 2025. This award is not associated with a set-aside program. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a multiomics...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland. The $180,000 contract has a period of performance ending on May 19, 2025. Psomagen Inc. is a subsidiary of the parent company Macrogen, Inc., which is a leading provider of genomic sequencing and bioinformatics services to the U.S. federal government. The contract does not have a...
- This firm-fixed price purchase order for $600,000 was awarded by the National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, to Psomagen, Inc. for whole genome sequencing services. Under the terms of the contract, Psomagen will sequence 1,000 human samples to 30x coverage using Illumina sequencing technologies and deliver raw sequencing data files within 4-6 weeks. The work will be performed in Potomac, Maryland over a one...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Psomagen Inc. for DNA and RNA sequencing of parental induced pluripotent stem cell (iPSC) lines. The contract has a ceiling value of $38,053.00 and a completion date of December 31, 2019. Psomagen Inc. is a wholly owned subsidiary of the larger company Macrogen, Inc. This award is an example of the sequencing and multi-omics services Psomagen provides to federal agencies...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government agencies, particularly within the health and agricultural sectors. The company has established itself as a key provider of advanced sequencing and omics services to various federal agencies, including the NIH, U.S. Department of Agriculture, and Smithsonian Institution. This contract is set aside for small businesses. Psomagen Inc. has also received federal grant sub-awards, including from the National Institute of Diabetes and Digestive and Kidney Diseases for the "The Environmental Determinants of Diabetes in the Young (TEDDY) Study." Additionally, Psomagen holds two significant federal contract Indefinite Delivery Vehicles (IDVs) from the USDA and NIH, further demonstrating the company's expertise and capacity in supporting critical federal research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($200) | 7/29/24 | |
| P00001 | Exercise an Option | $3.3m | 9/15/23 | |
| Not listed | Not listed | $577.5k | 7/20/23 |